References

1. 1.
   WANG L.Endometrial receptivity and embryo implantation and its research progress of traditional Chinese medicine treatment ［J］.Chin J Integr Tradit West Med， 2021， 41（2）： 172-176.
2. 2.
   LI A J.The expression and Significance of CD44v6，E-cadherin and Ang-1 in endometrium during the window of implantation of polycystic ovary syndrome ［D］.Zhengzhou：Zhengzhou University， 2014.
3. 3.
   WANG X， HE Y Q， LI Z L， et al. Mechanism exploration of Xiaoyaosan regulating endometrial receptivity in PCOS based on network pharmacology and its experimental verification［J］.J Hunan Univ Chin Med， 2023， 43（1）： 69-79.
4. 4.
   WANG X， HE Y Q， SU Y H， et al. Effects of formula for cycle therapy of tonifying kidney and regulating follicular on proliferation，secretion and expressions of AMH，AMHR2 and Smad4 of primary ovarian granulosa cells in rats ［J］. Tradit Chin Drug Res Clin Pharmacol， 2023， 34（7）： 904-913.
5. 5.
   CHEN L，YANG S，YOU Z L，et al.The regulation of bushen-follicle recuperation therapy on expression of AMH protein and receptor in PCO model rats［J］.Tradit Chin Drug Res Clin Pharmacol， 2019， 30（11）： 1314-1321.
6. 6.
   PALOMBA S，PILTONEN T T，GIUDICE L C. Endometrial function in women with polycystic ovary syndrome：A comprehensive review［J］.Hum Reprod Update，2021，27 （3）：584-618.
7. 7.
   LIN J J， ZENG D Y， LIU L， et al. Effect of modified Lianggu decoction on endometrial receptivity during the implantation window of ovulation induction model mice［J］.J Tradit Chin Med， 2021， 62（4）： 328-334.
8. 8.
   LI Y， CHEN J L， WU P W， et al. Effect of flavonoids in Cuscuta chinensi Lam. on endometrial receptivity during the implantation window in rats ［J］.J Guangzhou Univ Tradit Chin Med， 2022， 39（8）： 1886-1892.
9. 9.
   LI L， MA B L， HE B， et al. Improvement of paeoniflorin on endometrial receptivity in rats with polycystic ovary syndrome and influence on Wnt/β-catenin pathway［J］.Tradit Chin Drug Res Clin Pharmacol， 2024， 40（2）： 90-95.
10. 10.
    WANG T F， HE L Y， KANG X M， et al. Effect of aspirin on uterine hemodynamics in patients with early recurrent spontaneous abortion ［J］. J Shanghai Jiaotong Univ，2017， 7（4）： 518-522.
11. 11.
    YANG S. Follicle growth rule and clinical research on the diagnosis and treatment of the integrated Chinese and western medicine about polycystic ovary syndrome infertility ［D］.Changsha：Hunan University of Chinese Medicine， 2014.
12. 12.
    YANG J， LIN Q P， YOU X M， et al. Effect of combined treatment with acupuncture， moxibustion and medication on endometrial receptivity and expression of serum HOXA10 in polycystic ovary syndrome of kidney deficiency and blood stagnation［J］.Chin Acup Moxib， 2020， 40（11）： 1154-1158，1168.
13. 13.
    SUN X C， TAN L， DING N， et al. Theory and practice of treating infertility by nourishing the kidney in menstrual cycle Shanghai Cai's gynecology school［J］. J Beijing Univ Tradit Chin Med， 2023， 46（9）： 1213-1217.
14. 14.
    CHEN J， FAN H Y， ZENG J Z， et al. Clinical efficacy observation of electroacupuncture cycle therapy combined with clomiphene citrate treatment based on the theory of "Ren zhu Baotai" on polycystic ovary syndrome ［J］. Chin J Tradit Chin Med， 2024， 39（1）： 496-499.
15. 15.
    ROSENBLUTH E M，SHELTON D N，WELLS L M，et al. Human embryos secrete microRNAs into culture media-a potential biomarker for implantation［J］.Fertil Steril，2014，101 （5）：1493-1500.
16. 16.
    VILELLA F，MORENO-MOYA J M，BALAGUER N，et al. Hsa-miR-30d， secreted by the human endometrium， is taken up by the pre-implantation embryo and might modify its transcriptome［J］.Development，2015，142 （18）：3210-3221.
17. 17.
    LU N.Study on miR-140-5p affecting human endometrial receptivity via targeting VEGF［D］.Zhengzhou：Zhengzhou University， 2019.
18. 18.
    LU Y，QIN T，LI J，et al. MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer［J］.Cancer Gene Ther，2017，24 （9）：386-392.
19. 19.
    WANG X， HE Y Q， LIU Q， et al. Effects of cycle therapy of tonifying kidney and regulating liver and serum containing prescription on miR-140-5P/VEGF signaling pathway in Ishikawa cells［J］.Chin Tradit Patent Med， 2024， 46（8）： 2756-2762.
20. 20.
    HE M，LI L，WEI X，et al. Erratum to "Xiaoyao powder improves endometrial receptivity via VEGFR-2-mediated angiogenesis through the activation of the JNK and p38 signaling pathways"［J］.Ethnopharmacology，282 （2022） 114580.
21. 21.
    GUO X，YI H，LI T C，et al.Role of vascular endothelial growth factor （VEGF） in human embryo implantation： Clinical implications［J］.Biomolecules，2021，11 （2）：253.
22. 22.
    MU H， YANG R B， DU L， et al. Fetal growth restriction induced by VEGF abnormality［J］.Chin J Histochem Cytochem， 2021， 30（2）： 195-197，201.
23. 23.
    SADEKOVA O N，NIKITINA L A，RASHIDOV T N，et al. Luteal phase defect is associated with impaired VEGF mRNA expression in the secretory phase endometrium［J］.Reprod Biol，2015，15 （1）：65-68.
24. 24.
    WANG Z，NIE K，SU H，et al. Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome［J］.Phytomedicine，2021，91：153654.
25. 25.
    HAPANGAMA D K，KAMAL A M，BULMER J N. Estrogen receptor β：The guardian of the endometrium［J］.Hum Reprod Update，2015，21 （2）：174-193.
26. 26.
    XU X L，DENG S L，LIAN Z X，et al. Estrogen receptors in polycystic ovary syndrome［J］.Cells，2021，10 （2）：459.
27. 27.
    PAULSON M，SAHLIN L，HIRSCHBERG A L. Endometrial expression of anti-Müllerian hormone and its type Ⅱ receptor in women with polycystic ovary syndrome［J］.Reprod Biomed Online，2020，41 （1）：128-137.
28. 28.
    GIBSON D A，SIMITSIDELLIS I，COLLINS F，et al. Androgens， oestrogens and endometrium：A fine balance between perfection and pathology［J］.J Endocrinol，2020，246 （3）：R75-R93.
29. 29.
    PILTONEN T T. Polycystic ovary syndrome： Endometrial markers［J］.Best Pract Res Clin Obstet Gynaecol，2016，37：66-79.